![]() |
市场调查报告书
商品编码
1380421
2023-2030 年全球细胞分离技术市场Global Cell Separation Technology Market 2023-2030 |
预计全球细胞分离技术市场在预测期(2023-2030年)将以10.1%的CAGR成长。细胞分离技术是许多生命科学的关键部分,从干细胞和肿瘤学研究到常规临床诊断。成像和光谱技术的日益普及以及众多领域的发展是支持全球市场成长的关键因素。研究人员可以实现全光谱细胞分选,再加上新的模组化光学架构和系统感知演算法带来的扩展性能,从而在简化的工作流程中执行高参数实验。因此,市场参与者也专注于推出细胞分选仪器解决方案,以进一步促进市场成长。例如,2023年5月,医疗技术公司BD(Becton,Dickinson and Company)推出了一款新型细胞分选仪器,该仪器采用两项突破性技术,使研究人员能够发现有关细胞的更详细资讯。借助 BD CellView (TM) 影像技术,研究人员可以看到单一细胞的详细显微影像,并根据视觉特征进行高速分类,以即时确认见解。
全球细胞分离技术市场按类型、技术、应用和最终用户进行细分。根据类型,市场细分为仪器(离心机、流式细胞仪、过滤系统、磁激活细胞分离器系统)和消耗品(试剂、试剂盒、培养基和血清、珠子、一次性用品)。根据技术,市场细分为梯度离心、表面标记物分离、基于过滤的分离、免疫密度细胞分离和其他(微流控细胞分离)。根据应用,市场细分为肿瘤学、神经科学、干细胞研究、微生物学和免疫学。此外,根据最终用户,市场细分为研究实验室和研究所、生物技术和生物製药公司以及医院和诊断实验室。在这些技术中,由于分子生物学实验室经常采用的梯度离心技术的不断发展,梯度离心预计将占据相当大的市场份额。离心用于收集细胞、沉淀DNA、纯化病毒颗粒、区分分子构象的细微差异。
其中,磁激活细胞分离系统子领域预计将在全球细胞分离技术市场中占据相当大的份额。分段增长归因于磁性细胞分离对从生物悬浮液中分离目标细胞群的影响日益增长,涵盖从生物医学的诊断和治疗到环境应用或生物学基础研究的广泛应用。研究人员现在可以利用前所未有的样本处理能力和见解来加速他们的发现。一种透过磁浮分离和富集感兴趣细胞的温和、快速、公正的新方法。例如,2022 年 4 月,LevitasBio, Inc. 推出了 LeviCell (TM) EOS 系统,这是他们的下一代细胞分离和富集解决方案,具有更高的通量和同时有针对性地选择活细胞。
全球细胞分离技术市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,由于采用先进的技术解决方案,预计北美将在全球市场中占据显着份额。此外,研究型大学在细胞治疗领域的广泛研究活动对细胞分离解决方案产生了巨大的需求。
在所有地区中,亚太地区预计在预测期内将以相当大的CAGR成长。区域成长归因于中国和印度等新兴经济体製药和生物技术产业的成长。此外,日本、中国和韩国持续进行的干细胞和基因治疗研究措施也推动了该地区对细胞分离解决方案的需求。该地区慢性病盛行率的增加是细胞分离技术发展的主要驱动因素。根据美国国立卫生研究院 (NIH) 统计,2022 年 3 月,印度约 21.0% 的老年人据称患有至少一种慢性病。农村地区17.0%的老年人和城市地区29.0%的老年人患有慢性病。
对人类和癌症研究的日益关注以及分离的人类细胞在生物製药开发、临床试验和研究中的各种应用是促进市场成长的主要因素。此外,已开发国家个人化医疗的优惠报销政策刺激了人体细胞分离的需求。主要市场参与者包括索尼生物技术、Miltenyi Biotec Japan、Himedia Laboratories、Magcrown Biotech、Sinobioway Biomedicine、NanoEntek、Bioneer Corp 等。
Title: Global Cell Separation Technology Market Size, Share & Trends Analysis Report by Type (Instruments and Consumables), by Technology (Gradient Centrifugation, Surface Markers Separation, Filtration Based Separation, Immunodensity Cell Separation, and Others), by Application (Oncology, Neuroscience, Stem Cell Research, Microbiology, and Immunology), and by End Users (Research Laboratories & Institutes, Biotechnology & Biopharmaceutical Companies and Hospitals & Diagnostic Laboratories)Forecast Period (2023-2030).
The global cell separation technology market is anticipated to grow at a CAGR of 10.1% during the Forecast Period (2023-2030). Cell separation technology is a key part of many life sciences, from stem cell and oncology research to routine clinical diagnosis. The growing adoption of imaging and spectral technologies with the development across numerous fields is the key factor supporting the growth of the market globally. Researchers can achieve full-spectrum cell sorting, coupled with expanded performance enabled by a new modular optical architecture and system-aware algorithms, to perform high-parameter experiments within a simplified workflow. Hence, the market players are also focusing on introducing cell sorting instrument solutions that further bolster the market growth. For instance, in May 2023, BD (Becton, Dickinson and Company), A medical technology company, launched a new cell sorting instrument featuring two breakthrough technologies that enable researchers to uncover more detailed information about cells. With BD CellView™ Image Technology, researchers can see detailed microscopic images of individual cells and sort at high speeds based on visual characteristics to confirm insights in real time.
The global cell separation technology market is segmented on the type, technology, application and end users. Based on the type, the market is sub-segmented into Instruments (centrifuges, flow cytometers, filtration systems, magnetic-activated cell separator systems) and consumables (reagents, kits, media, and sera, beads, disposables). Based on the technology, the market is sub-segmented into gradient centrifugation, surface markers separation, filtration-based separation, immunodensity cell separation and others (microfluidic cell separation). Based on the application, the market is sub-segmented into oncology, neuroscience, stem cell research, microbiology and immunology. Further, on the basis of end user, the market is sub-segmented into research laboratories & institutes, biotechnology & biopharmaceutical companies and hospitals & diagnostic laboratories. Among the technology, the gradient centrifugation sub-segment is anticipated to hold a considerable share of the market owing to the rise in development of gradient centrifugation that frequently employed techniques in the molecular biology laboratory. Centrifugation is used to collect cells, to precipitate DNA, to purify virus particles, and to distinguish subtle differences in the conformation of molecules.
Among the type, the magnetic-activated cell separator systems sub-segment is expected to hold a considerable share of the global cell separation technology market. The segmental growth is attributed to the growing influence of the magnetic cell separation for the isolation of target cell populations from biological suspensions, covering a wide spectrum of applications from diagnosis and therapy in biomedicine to environmental applications or fundamental research in biology. Researchers can now accelerate their discoveries with unprecedented sample processing power and insights. A new gentle, fast, and unbiased method to separate and enrich cells of interest via magnetic levitation. For instance, in April 2022, LevitasBio, Inc. launched the LeviCell™ EOS System, their next-generation solution for cell separation and enrichment, featuring higher throughput and simultaneous targeted selection of viable cells.
The global cell separation technology market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the adoption of advanced technologically solutions. Furthermore, extensive research activities by research universities in the field of cell therapies have created a huge demand for cell separation solutions.
Among all regions, the Asia-Pacific regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to growing pharmaceutical and biotechnology industries in emerging economies, such as China and India. Furthermore, continuous stem and gene therapy research initiatives in Japan, China, and South Korea have boosted the demand for cell separation solutions in the region. An increase in the prevalence of chronic disease in the region is the major driving factor for the growth of cell separation technology. According to the National Institute of Health (NIH), in March 2022, About 21.0% of the elderly in India reportedly have at least one chronic disease. 17.0% elderly in rural areas and 29.0% in urban areas suffer from a chronic diseases.
The rising focus on human & cancer research and varied applications of isolated human cells in biopharmaceutical development, clinical trials, and research are among the major factors contributing to market growth. Moreover, favorable reimbursement policies pertaining to personalized medicine in developed countries boost the demand for human cell isolation. The key market players include Sony Biotechnology, Miltenyi Biotec Japan, Himedia Laboratories, Magcrown Biotech, Sinobioway Biomedicine, NanoEntek, Bioneer Corp and others.
The major companies serving the global cell separation technology market include: Corning Inc., Genscript Biotech Corp., Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, Applied Cells Inc. and STEMCELL Technologies Inc. collaborated to deliver a new high-performance cell separation solution that combines Applied Cells' MARS® platform with STEMCELL's EasySep™ immunomagnetic cell separation kits. This partnership helps researchers around the world to automate and increase the efficiency of isolating high-quality cells from a wide range of sample types.